Skip to content

 

Delivering Value to Investors

A global leader in DNA sequencing and array-based technologies, Illumina is fueling advancements in life sciences, oncology, reproductive health, genetic disease, agriculture, microbiology, and other emerging segments. We are dedicated to improving human health by unlocking the power of the genome. That mission is behind everything we do, from enabling breakthroughs that move us closer to the realization of precision medicine to delivering value to our investors.

Investor Events
July 29, 2019 | 17:00 ET
Q2 2019 Illumina, Inc. Earnings Conference Call
June 12, 2019 | 10:00 PT
Goldman Sachs 40th Annual Global HC Conference
May 29, 2019 | 10:00 PT
Illumina 2019 Annual Shareholder Meeting
View All Events & Presentations